Literature DB >> 27630001

Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa.

E Keane1,2, A L Funk3, Y Shimakawa4.   

Abstract

BACKGROUND: The risk of mother-to-child transmission of hepatitis B virus (HBV) has been quoted as 70-90% among women positive for hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), and 5-30% among HBsAg-positive HBeAg-negative women. These risks are derived from Asia; little is known about sub-Saharan Africa. AIM: To determine the risk of mother-to-child transmission in sub-Saharan Africa, according to maternal HBeAg and type of prophylaxis.
METHODS: We searched Medline, Global Health, Embase, African Journals Online and African Index Medicus. We included observational or interventional studies that enrolled infants of HBV-infected women, and that tested for HBsAg or HBV DNA between 3 and 12 months of age.
RESULTS: Fifteen articles from 11 African countries were included. Among HBeAg-positive women, the pooled risk was 38.3% (95% CI: 7.0-74.4%) without prophylaxis, which was significantly lower than the lower bound of 70-90% risk in the literature (P = 0.007). Among HBeAg-negative women, the pooled risk was 4.8% (95% CI: 0.1-13.3%) without prophylaxis, which lays within the lower range of the 5-30% risk in Asia. By extrapolating the pooled transmission risks to the number of births to infectious mothers, an estimated 1% of newborns (n = 367 250) are annually infected with HBV at birth in sub-Saharan Africa.
CONCLUSIONS: Compared to Asia, the risk of mother-to-child transmission is low in sub-Saharan Africa. However, the annual number of infants perinatally infected with HBV is twice the number of incident paediatric HIV infections in sub-Saharan Africa (n = 190 000). This highlights the importance of preventing mother-to-child transmission of HBV in sub-Saharan Africa, which has been long neglected.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27630001     DOI: 10.1111/apt.13795

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  39 in total

1.  Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.

Authors:  Jodie Dionne-Odom; Andrew O Westfall; Divine Nzuobontane; Michael J Vinikoor; Gregory Halle-Ekane; Thomas Welty; Alan T N Tita
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

Review 2.  Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.

Authors:  Jodie Dionne-Odom; Basile Njei; Alan T N Tita
Journal:  Clin Ther       Date:  2018-07-05       Impact factor: 3.393

3.  Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa.

Authors:  Peyton Wilson; Jonathan B Parr; Ravi Jhaveri; Steve R Meshnick
Journal:  J Infect Dis       Date:  2018-03-28       Impact factor: 5.226

4.  Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers.

Authors:  Wenjun Zhang; Chenyu Xu; Yanjing Rui; Jie Chen; Tingmei Chen; Yimin Dai; Biyun Xu; Yali Hu; Junhao Chen; Yi-Hua Zhou
Journal:  J Virus Erad       Date:  2022-06-20

5.  Assessment of hepatitis B knowledge and awareness among the Sudanese population in Khartoum State.

Authors:  Omer Osman Kheir; Catherine Freeland; Abdelmounem Eltayeib Abdo; Mortada Elrashid Mohamed Yousif; Eilaf Osama Altayeb; Hailemichael Desalegn Mekonnen
Journal:  Pan Afr Med J       Date:  2022-03-16

6.  Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa.

Authors:  Abdoulaye Seck; Fatou Ndiaye; Sarah Maylin; Babacar Ndiaye; François Simon; Anna L Funk; Arnaud Fontanet; Kazuaki Takahashi; Sheikh Mohammad Fazle Akbar; Shunji Mishiro; Raymond Bercion; Muriel Vray; Yusuke Shimakawa
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

7.  Is hepatitis B birth dose vaccine needed in Africa?

Authors:  Cynthia Raissa Tamandjou; Tongai Gibson Maponga; Nafiisah Chotun; Wolfgang Preiser; Monique Ingrid Andersson
Journal:  Pan Afr Med J       Date:  2017-06-22

8.  Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.

Authors:  Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe
Journal:  Elife       Date:  2021-07-13       Impact factor: 8.140

9.  Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).

Authors:  Haoua Tall; Pierrick Adam; Abdoul Salam Eric Tiendrebeogo; Jeanne Perpétue Vincent; Laura Schaeffer; Cassandre von Platen; Sandrine Fernandes-Pellerin; François Sawadogo; Alkadri Bokoum; Ghislain Bouda; Seydou Ouattara; Issa Ouédraogo; Magali Herrant; Pauline Boucheron; Appolinaire Sawadogo; Edouard Betsem; Alima Essoh; Lassané Kabore; Amariane Ouattara; Nicolas Méda; Hervé Hien; Andréa Gosset; Tamara Giles-Vernick; Sylvie Boyer; Dramane Kania; Muriel Vray; Yusuke Shimakawa
Journal:  Vaccines (Basel)       Date:  2021-06-01

10.  Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.

Authors:  Purusotam Raj Shedain; Madhu Dixit Devkota; Megha Raj Banjara; Huang Ling; Subash Dhital
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.